Neil Fleshner
Neil Fleshner
Verified email at
Cited by
Cited by
Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer
MJ Zelefsky, SA Leibel, PB Gaudin, GJ Kutcher, NE Fleshner, ...
International Journal of Radiation Oncology* Biology* Physics 41 (3), 491-500, 1998
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
MC Liu, GR Oxnard, EA Klein, C Swanton, MV Seiden, MC Liu, ...
Annals of Oncology 31 (6), 745-759, 2020
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
FR Schumacher, AA Al Olama, SI Berndt, S Benlloch, M Ahmed, ...
Nature genetics 50 (7), 928-936, 2018
Sensitive tumour detection and classification using plasma cell-free DNA methylomes
SY Shen, R Singhania, G Fehringer, A Chakravarthy, MHA Roehrl, ...
Nature 563 (7732), 579-583, 2018
Genomic hallmarks of localized, non-indolent prostate cancer
M Fraser, VY Sabelnykova, TN Yamaguchi, LE Heisler, J Livingstone, ...
Nature 541 (7637), 359-364, 2017
Active surveillance of small renal masses: progression patterns of early stage kidney cancer
MAS Jewett, K Mattar, J Basiuk, CG Morash, SE Pautler, DR Siemens, ...
European urology 60 (1), 39-44, 2011
Spatial genomic heterogeneity within localized, multifocal prostate cancer
PC Boutros, M Fraser, NJ Harding, R De Borja, D Trudel, E Lalonde, ...
Nature genetics 47 (7), 736-745, 2015
Feasibility study: watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen …
R Choo, L Klotz, C Danjoux, GC Morton, G DeBoer, E Szumacher, ...
The Journal of urology 167 (4), 1664-1669, 2002
Designing the selenium and vitamin E cancer prevention trial (SELECT)
SM Lippman, PJ Goodman, EA Klein, HL Parnes, IM Thompson, ...
Journal of the National Cancer Institute 97 (2), 94-102, 2005
Impact of androgen deprivation therapy on cardiovascular disease and diabetes
SMH Alibhai, M Duong-Hua, R Sutradhar, NE Fleshner, P Warde, ...
Journal of clinical oncology: official journal of the American Society of …, 2009
Cancer-related fatigue and associated disability in post-treatment cancer survivors
JM Jones, K Olson, P Catton, CN Catton, NE Fleshner, MK Krzyzanowska, ...
Journal of Cancer Survivorship 10, 51-61, 2016
Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction
DV Conti, BF Darst, LC Moss, EJ Saunders, X Sheng, A Chou, ...
Nature genetics 53 (1), 65-75, 2021
Correlation between Gleason score of needle biopsy and radical prostatectomy specimen: accuracy and clinical implications
MS Cookson, NE Fleshner, SM Soloway, WR Fair
The Journal of urology 157 (2), 559-562, 1997
Epidemiology and prevention of prostate cancer
G Gandaglia, R Leni, F Bray, N Fleshner, SJ Freedland, A Kibel, P Stattin, ...
European urology oncology 4 (6), 877-892, 2021
Prevalence of prostate cancer on autopsy: cross-sectional study on unscreened Caucasian and Asian men
AR Zlotta, S Egawa, D Pushkar, A Govorov, T Kimura, M Kido, ...
Journal of the National Cancer Institute 105 (14), 1050-1058, 2013
Metformin use and all-cause and prostate cancer-specific mortality among men with diabetes
D Margel, DR Urbach, LL Lipscombe, CM Bell, G Kulkarni, PC Austin, ...
J Clin Oncol 31 (25), 3069-3075, 2013
Propensity score analysis of radical cystectomy versus bladder-sparing trimodal therapy in the setting of a multidisciplinary bladder cancer clinic
GS Kulkarni, T Hermanns, Y Wei, B Bhindi, R Satkunasivam, ...
Journal of clinical oncology 35 (20), 2299-2305, 2017
Serum and tissue lycopene and biomarkers of oxidation in prostate cancer patients: a case-control study
AV Rao, N Fleshner, S Agarwal
Nutrition and cancer 33 (2), 159-164, 1999
30-day mortality and major complications after radical prostatectomy: influence of age and comorbidity
SMH Alibhai, M Leach, G Tomlinson, MD Krahn, N Fleshner, E Holowaty, ...
Journal of the National Cancer Institute 97 (20), 1525-1532, 2005
Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial
NE Fleshner, MS Lucia, B Egerdie, L Aaron, G Eure, I Nandy, L Black, ...
The Lancet 379 (9821), 1103-1111, 2012
The system can't perform the operation now. Try again later.
Articles 1–20